TSS
KAPA

Two Sigma Securities’s Kairos Pharma KAPA Stock Holding History

Two Sigma Securities’s Portfolio KAPA Stock Details KAPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,321
Closed -$9.08K – 2504
2026
Q1 		$9.08K Buy
+2,321
New +$10.9K ﹤0.01% 1475
2025
Q4 		– Sell
-3,556
Closed -$29.1K – 2132
2025
Q3 		$29.1K Buy
3,556
+1,620
+84% +$13K ﹤0.01% 1070
2025
Q2 		$9.61K Buy
+1,936
New +$9.86K ﹤0.01% 1304

Other funds holding KAPA

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
SFG
SevenBridge Financial Group Harrisburg, Pennsylvania $680M AUM 30.75% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Two Sigma Securities's KAPA Position: Q2 2026 in Review

Two Sigma Securities sold out of Kairos Pharma (KAPA) in Q2 2026, closing a stake of 2,321 shares — an estimated $9.08K sold.

Two Sigma Securities first reported a position in KAPA in Q2 2025 and held it in 3 quarters. The position peaked at $29.1K in Q3 2025. 14 funds tracked by Wall St. Rank hold KAPA as of Q2 2026.

  • Two Sigma Securities reported no remaining Kairos Pharma position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 2,321 Kairos Pharma shares in Q2 2026, an estimated $9.08K.
  • Two Sigma Securities first reported a position in Kairos Pharma in Q2 2025 and held it in 3 quarters.
  • Two Sigma Securities's Kairos Pharma position peaked at $29.1K in Q3 2025.
  • 14 funds tracked by Wall St. Rank held Kairos Pharma as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.